What is LH's five-year median P/E?

28.6x. Half of LH's weekly readings since July 2023 were higher and half were lower. This page has 174 weekly readings, from Jul 3, 2023 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares LH only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Labcorp (LH) valuation history

Health Care

$368.16

Latest weekly close · Market cap $30.2B

Within its usual range

Labcorp's P/E of 30.5x is higher than 64% of its weekly readings since July 2023 (as of Oct 30, 2026).

Forward P/E 16.6× (analyst estimates, not ranked).

Weekly P/E since July 2023

P/E each weekMiddle half of its readingsMedian 28.6×

Median: 28.6×
Low to high: 18.8× to 47.5×
Versus median: +6%
History starts: July 2023

P/E

64thpercentile

of its weekly readings since July 2023

Growth, last 12 months vs the year before

Revenue: +6%decelerating
EPS: +33%

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends.

PriceRevenue, last 12 monthsEPS, last 12 months100 = first reading

P/E at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

LH P/E at each year-end
Year-end	P/E	5-year percentile
Dec 29, 2025	24.7×	14
Dec 30, 2024	43.6×	82
Dec 25, 2023	30.0×	98

Health Care peers on P/E

Each percentile compares a stock with its own last five years.

Compare LH with peers

Health Care peers of LH on P/E
Stock	P/E	Versus its own history	5-year percentile
CHEChemed Corp	26.0×	Below its usual range	29
CICigna	12.3×	Below its usual range	26
CVSCVS Health	23.8×	Above its usual range	71
DGXQuest Diagnostics	25.2×	Historically high	98
DVADaVita	14.3×	Within its usual range	48

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on LH

No articles about LH yet. How valuation percentiles work

Loading peers and related research…

About this history

What is LH's current P/E?: Labcorp's P/E of 30.5x is higher than 64% of its weekly readings since July 2023 (as of Oct 30, 2026).
What is LH's five-year median P/E?: 28.6x. Half of LH's weekly readings since July 2023 were higher and half were lower. This page has 174 weekly readings, from Jul 3, 2023 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares LH only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.